Email Forum    |    Search

Ask Dr. Stephan Moll

These questions have been submitted by folks on the mailing list and answered by Dr. Moll, Director of the Thrombophilia Program at the Carolina Cardiovascular Biology Center, Department of Medicine, Division of Hematology-Oncology, UNC Chapel Hill (North Carolina, USA). Why am I doing this?

Print Question

37. Pilot Thrombophilia Centers in the U.S.

Last Updated: 2/15/2004


Q: "How come there are well structured Hemophilia Centers all over the U.S., but no Thrombophilia Centers? I thought clotting disorders are much more common than hemophilia. Why do we not have anybody looking after us?"

A: Thrombophilia is indeed much more common than hemophilia. There are more than 100 Comprehensive Hemophilia Centers in the U.S., but until October 2001 there were no federally funded Thrombophilia Centers. The consequence is suboptimal care for patients with thrombophilia and a lack of thrombophilia research. The Center for Disease Control in Atlanta started funding 8 Thrombophilia Center pilot sites in November 2001. Goal is to collect data about the activities of these centers and the beneficial effect they have on patient care, to then go to Congress and make a case for funding of a large number of Thrombophilia Centers all over the U.S., so that everybody has access to medical care by a Thrombosis Specialist and that everybody gets the best possible care. There is a probably a need for more than 200 such centers. The important role of patient advocacy groups in making a case for such Centers to Congress is discussed in Q/A 36.

Some numbers (for U.S. population; approximation)

  1. Hemophilia
    • 28,000 have hemophilia A
    • ·5,000 have hemophilia B
  2. Thrombophilia
    • 13 million are heterozygous for factor V Leiden
    • 170,000 are homozygous for factor V Leiden
    • 5,6 million are heterozygous for prothrombin 20210 mutation
    • 28,000 are homozygous for prothrombin 20210 mutation
    • 70,000 are heterozygous for factor V Leiden plus heterozygous for prothrombin 20210 mutation
    • more than 200,000 people develop a DVT or PE every year
    • more than 60,000 people die every year from pulmonary embolism
CDC (Center for Disease Control) activities
The CDC has realized that Thrombophilia Centers are needed to improve the care of patients with thrombosis and individuals with thrombophilia. Finances from Congress are needed to create a large number of comprehensive Thrombophilia Centers spread all over the U.S. As an initial step the CDC designated 8 sites in the U.S. October 2001 as Thrombophilia Pilot sites, providing them with some funding (for thrombophilia nurses, data coordinators, and/or genetic counselors). Goal is to create structures that identify the needs of patients with thrombophilia and improve their care, to then demonstrate to the U.S. Congress that care of individuals with thrombophilia and patients with thrombosis at present is inadequate, and that it can be improved by creation of specialized Thrombophilia Centers. The 8 pilot sites are (alphabetically): Hemophilia Centers
Many of the more than 100 U.S. Hemophilia Centers are now also focusing on thrombosis and thrombophilia. Specialist care can be received in many of these centers. A list of these centers can be found on the web at the CDC

<< Back To Ask The Doctor...

Disclaimer
The information contained on the this web site is provided for your general information only. I am not a doctor and I do not give medical advice or engage in the practice of medicine. I do not recommend any particular treatment/trial for individuals, and in all cases recommend that you consult your physician or local treatment center before pursuing any course of treatment. It is up to you, as a consumer to find out if these trials posted are something you want to participate in. I just post the information.
spacer